Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sabby Management, Llc


  • Large Shareholder at Rosetta Genomics Ltd. (ROSGQ), 2019-04-22
  • Large Shareholder at Reshape Lifesciences Inc. (RSLS), 2019-02-04
  • Large Shareholder at Celsus Therapeutics Plc. (CLTX), 2014-04-23
  • Large Shareholder at Nupathe Inc. (PATH), 2012-11-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RSLS $0.00 1,192,000 Large Shareholder 507 2019-02-01 Filing
RSLS $0.27 10,301 Large Shareholder 1,192,507 2019-01-31 Filing
RSLS $0.28 48,000 Large Shareholder 1,182,206 2019-01-30 Filing
RSLS $0.28 12,200 Large Shareholder 1,134,206 2019-01-29 Filing
RSLS $0.27 15,595 Large Shareholder 1,122,006 2019-01-25 Filing